Prostate cancer in transgender women.

[1]  Ze Chen,et al.  Breast and reproductive cancers in the transgender population: a systematic review , 2018, BJOG : an international journal of obstetrics and gynaecology.

[2]  A. Kishan,et al.  Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer , 2018, JAMA.

[3]  Ariella R. Tabaac,et al.  Gender Identity Disparities in Cancer Screening Behaviors. , 2018, American journal of preventive medicine.

[4]  Liangyuan Hu,et al.  Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Chin-Lee Wu,et al.  Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2 , 2017, The Journal of pathology.

[6]  P. Cohen-Kettenis,et al.  Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline , 2017, The Journal of clinical endocrinology and metabolism.

[7]  Todd McNutt,et al.  Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. , 2017, International journal of radiation oncology, biology, physics.

[8]  L. Kovacs,et al.  Combined vaginoplasty technique for male-to-female sex reassignment surgery: Operative approach and outcomes. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[9]  R. Autorino,et al.  Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges. , 2017, Urology.

[10]  M. Parmar,et al.  Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy , 2017, The New England journal of medicine.

[11]  G. Prins,et al.  The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role? , 2017, The Prostate.

[12]  J. Safer,et al.  What Surgeons Need to Know About Gender Confirmation Surgery When Providing Care for Transgender Individuals: A Review , 2017, JAMA surgery.

[13]  V. Dalton,et al.  Transgender Demographics: A Household Probability Sample of US Adults, 2014. , 2017, American journal of public health.

[14]  Stephen Whittle,et al.  Transgender people: health at the margins of society , 2016, The Lancet.

[15]  S. Reisner,et al.  Beyond Bathrooms--Meeting the Health Needs of Transgender People. , 2016, The New England journal of medicine.

[16]  E. Coleman,et al.  Barriers to healthcare for transgender individuals , 2016, Current opinion in endocrinology, diabetes, and obesity.

[17]  M. Matrana,et al.  Metastatic Prostate Cancer 35 Years After Sex Reassignment Surgery. , 2016, Clinical genitourinary cancer.

[18]  L. Gooren,et al.  Sex reassignment of transsexual people from a gynecologist's and urologist's perspective , 2015, Acta obstetricia et gynecologica Scandinavica.

[19]  L. Gooren,et al.  Prostate cancer incidence in orchidectomised male‐to‐female transsexual persons treated with oestrogens , 2014, Andrologia.

[20]  P. V. van Diest,et al.  Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. , 2013, The journal of sexual medicine.

[21]  S. Reisner,et al.  Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. , 2013, American journal of public health.

[22]  S. Prescott,et al.  Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[23]  C. Beyrer,et al.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[24]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[25]  J. Snelgrove,et al.  “Completely out-at-sea” with “two-gender medicine”: A qualitative analysis of physician-side barriers to providing healthcare for transgender patients , 2012, BMC Health Services Research.

[26]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[27]  C. L. Cutajar,et al.  External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. , 2010, The Lancet. Oncology.

[28]  Z. Nugent,et al.  The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy team. , 2010, Brachytherapy.

[29]  A. Danoff,et al.  Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. , 2009, American journal of public health.

[30]  R. Miksad,et al.  DETECTION OF PROSTATE CANCER FOLLOWING GENDER REASSIGNMENT , 2007, BJU international.

[31]  T. Dorff,et al.  Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient. , 2007, Clinical genitourinary cancer.

[32]  I. Kaplan,et al.  Prostate cancer in a transgender woman 41 years after initiation of feminization. , 2006, JAMA.

[33]  D. Newling,et al.  Metastatic prostatic carcinoma in a male-to-female transsexual. , 1998, British journal of urology.

[34]  A. Thurston Carcinoma of the prostate in a transsexual. , 1994, British journal of urology.

[35]  S. Winter Lost in transition: transgender people,. Rights and HIV vulnerability in the Asia-Pacific region , 2012 .

[36]  C. Markland Transexual surgery. , 1975, Obstetrics and gynecology annual.